<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 285 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page284.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=285">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 285 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 285</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=285"><img src="../thumb/285.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>248 / 2020-04                                                             Anti-Microbials - 18.9
   matolog./liv. & ren.funct. tests advis.dur.prolong.treatm., reg. eval. of   Side effects: Thrombocytopen., bld.dyscras., hypersens. reacts.,   sequent.use of neuro- &/ nephrotox.meds.or in prolong.treatm.of
   pt.condit.essent., superinfect., monit.ren. & audit. funct. in prolong.  sev.skin reacts.incl.exfol. dermatit./ tox.epiderm.necrolys./erythema   pts.with ren.insuffic., not to be mix.in same sol.with aminoglycosid.
   treatm.in ren.insuffic. /concurr./sequent.use of neuro-&/ nephrotox.   multiforme incl.Stev.Johns.syndr., prurit., fev., rigors, angioed., bron-
   meds., not to be mix.in same sol.with aminoglycosid.  chosp., anaphylax., infus. relat.reacts. incl.upp.body flush./red-man   TYGACIL, Pfizer &
                                                              Tigecycline
   MYLAN VANCOMYCIN, Mylan [P/S]  syndr., headache, dizzin., hear.loss/tinnit./vestibul. disturbs./ ototoxic.,   Indications: Sev.life-threat.complic.skin & skin struct.infects. &
   Vancomycin HCl equiv.to vancomycin.  GI disturbs., ren.impairm./ fail., skin/inj.site reacts.  complicat.intra-abdom.infects.in adults
   Indications: Methicill.-resist.staphylococ. infects., ser.staphylococ.  Special precautions: Not known if pass.into breast milk, van-  (S4) POWD.FOR IV INFUS., A40/20.1.1/0230
   infects.in penicill. allerg. pts./pts.who fail to respond to penicill./   comycin-cross-sens., period. haematolog.studies/liv.& ren.funct.  713290-001: 50 mg/5 ml vial, 10, R10 662,21
   cephalosporin & ser.vancomycin suscept.organ. infects.resist.to other   tests advis., monit.ren.& audit.funct.in prolong.treatm.in ren. in-  Dosage: Treatm.durat.5-14 days accord.to sev.& site of infect.&
   antimicrob.agents, endocardit., staphylococc.enterocolt.& antibiot.-  suffic., concurr./sequent.use of neuro- &/ nephrotox. meds., incr.  clinic.& bacteriologic.progress. Flush line bef.& aft.infus.if same IV
   assoc.C.difficile pseudomembr.colit.  nephrotox.risk with concom. aminoglycosid., superinfect., reg.eval.  line used for sequent.infus.of sev.drugs.
   (S4) POWD.FOR SOL, 41/20.1.1/0571, 0572  of pt.condit. essent., monit.ther.in ren.insuff., not to be mix.in same   Admin.by IV infus.over 30-60 mins. Init.100 mg follow.by 50 mg 12 hrly.
   714111-001: 500 mg, 10x10 ml vials, R930,57  sol.with aminoglycosid.  Contraindications: Pregn.& lactat., not recomm. in childr.und.18
   714112-001: 1 g, 10x20 ml vials, R1 861,13  TARGOCID, Sanofi-Aventis [P/S]  yrs., safety & effic.in hosp.acquir. pneumon.not est.
   Dosage: Admin IV. Max.admin.rate: 500 mg /½hr. Close monit.of   Teicoplanin.  Side effects: Dizzin., prolong.activ.part. thromboplast. time & pro-
   ser.Vancomycin warrant.      Indications: Potent.ser.G(+) infects.incl.those that cannot be treat.  thrombin time. incr.INR, anaphylax., loc.reacts., GI disturbs., pancre-
   Adults: 500 mg 6 hrly or 1 g 12 hrly. Childr: 40 mg/kg bm/day in div.  with other antimicrob., prophylax. in orthopaed./vasc.surg., anti-  atit., hepat. cholestas., elev.AST & ALT post ther., signific. hepat.dys-
   dos. Infts.& neonates: Init: 15 mg/kg follow.by 10 mg/kg 12 hrly in   biot.assoc. diarrh.incl. pseudomembran.colit., CAPD assoc.peritonit.  funct.& hepat.fail., skin rash, headache, super infect.
   first week of life and 8 hrly thereaft.up to 1 mnth.of age   (S4) INJ. Z/20.1.1/61, 32/20.1.1/0337, Z/34/159.  Special precautions: Known tetracycline hypersens., perman.tooth
   Antibiot.-assoc.C.difficile pseudomembr. colit: Admin.orally.   826774-008: 200 mg, 2 vials, R2 116,20  discol., pseudomembr colit., monit.prothromb.time/other anticoag-
   Dissolv.dos.in 30 ml water/ flav.water. Adult tot.dly.dos: 500 mg-2 g   876909-004: 400 mg, 1 vial, R2 084,84  ulat. tests with concom.warfar., sev.hepat.impairm. (Child Pugh C),
   in 3-4 div.dos.x7-10 days. Childr.tot.dly.dos: 40 mg/kg bm in 3-4 div.  Dosage: Admin.as once daily dos.either IV or IM. IV inj.as either   fatalit.represent.complicat.of underly. dis/dis.progress.with no caus.
   dos. Tot.dly.dos.not to exceed 2 g.  bolus or 30 min.infus.  relationship est., monother.in complicat.intra-abdom.infects. second.
   Contra-indications: Safety in pregn.& lactat not est.  Adults & elderly pts.with norm.ren.funct: Mod.infects: Load.dos:   to clinic.apparent intestin.perforat., due to struct. similarit.advers.effs.
   Side-effects: Nephrotoxic., ototoxic.incl.hear. loss, neutropen.,   400 mg as sngl.IV inj.on 1st day. Maint: 200 mg dly.IV/IM  simil.to tetracycl.poss.
   thrombocytopen., naus., skin rash incl.exfoliat.dermatit., Stev.John.  Sev.infects: Load.dos: 400 mg IV 12 hrly.for first 3 dos. Maint:   Drug interactions: OC’s poss.less effect.
   syndr., tox.epiderm.necrolys, vasculit., super-infect., hypersens.reacts.  400 mg dly.IV/IM  See also MDR page 655.
   incl.anaphylactoid reacts.,  Prophylax.in orthopaed.& vasc.surg: 400 mg as sngl.IV inj.at
   Special precautions: Ren.dysfunct., elderly, signific.system.ab-  induct.of anaesthes.  URIZONE, AI Pharm Ltd [P/S] &
   sorpt.poss.with intestin. mucos. inflammat.disords.   Antibiot.assoc.diarrh: Admin.reconstitut. contents of a vial oral.200   Fosfomycin trometamol equiv.to fosfomycin.
   Drug interactions: Incr.toxic.risk with other ototox./nephrotox.drugs,   mg 2xdly.for 10 days.  Indications: Ac.uncomplic.E.Coli sens.lower UTI in women & fem.
   neuromusc.block.of suxamethonium & vecuronium incr.  Childr:  childr.over 5 yrs., prophylax.in diagn. & surgic.trans.urethr.proced.
                                                         st
   PHARMA-Q CLINDAMYCIN INJECTION 600 mg/4 ml,   Sev.infects.& neutropen.pts: 10 mg/kg 12 hrly by IVI for 1 .3 dos.  in adult men.
   Pharma-Q [P/S]               then 10 mg/kg IV/IM as sngl. dly.dos.  (S4) GRAN. 28/20.1.1/0480.
                                                              814210007: 3 g, 1 sachet, R227,01
                                                   st
   Clindamycin phosph.          Mod.infects: 10 mg/kg 12 hrly by IVI for 1  3 dos. then 6 mg/kg
   Indications: Ser.suscept.anaerob.infects., sev. staphylococ./strep-  IV/IM as sngl.dly.dos.  Dosage: Reconstit.in water & take at least 2 hrs. bef. next meal.
                                                              Adult women up to 75 yrs: Sngl.3 g dos. Fem. childr. over 5
                                                         st
   tococ.infects.incl. staphylococ. osteomyelit.  CAPD: Sngl.IV load.dos.of 400 mg, then 20 mg/L /bag in 1  week;
                                          nd
   (S4) INJ. 32/20.1.1/0502. 600 mg/4 ml  20 mg/L/alt.bags in 2  week & 20 mg/ L in overnight dwell.bag   yrs: sngl 2 g dos.
                                    rd
   703672-002: 10x 5 ml amps, R131,84  only in 3  week.       Trans.urethr.proced.prophylax: Adult men: Sngl.3 g dos.3 hrs.
   Dosage: IM admin.            Contraindications: Inj.into subarachnoid space, safety & effic.in   bef.surg.& 2nd 3 g dos.24 hrs. aft. surg.
   Adults: Mild to mod.infects: 600 mg/day in 2 equal dos. Mod.sev.  childr.und.3 yrs.& in pregn.& lactat. not est.  Contraindications: Sev.ren.insuffic., lactat., safety & effic.in
   infects: 600-1 200 mg/day in 2,3 or 4 equal dos.  Side effects: GI disturbs., hypersens., anaphylact. reacts./shock, loc.  pregn.& childr.und.5 yrs. not est., concom.metoclopramide.
   Sev.infects: 1 200-2 700 mg/day in 2,3 or 4 equal dos.  reacts., bld.dyscras., headache, dizzin., loss of hear., tinnit., vestibul.  Side effects: GI disturbs., skin rash, headache, naus.
   Childr.over 1 mnth: Mild to mod.infects: 10-15 mg /kg/day in   disturbs.in combinat. with ototox.drugs, superinfects.  Special precautions: Cross.into breast milk.
   3 or 4 equal dos.            Special precautions: Vancomycin-cross-sensit., ren. impairm.,   Drug interactions: Concom.metoclopramide.
   Mod.to sev.infects: 15-25 mg/kg/day in 3 or 4 equal dos. Sev.in-  monit.ren.& audit.funct.in concurr./ sequent. use of neuro/ne-  VANCOCIN CP 500 mg & 1 g, Sandoz [P/S]
   fects: 25-40 mg/kg/day in 3 or 4 equal dos.with no less than 300 mg/  phrotox.meds  Vancomycin HCl (chromatographically purified).
   day recomm. regardless of bm.                              Indications: Methicillin resist.staphylococc. infects., sev.staphylo-
   IV infusion: Admin.as sngl.rapid infus.of init.dos. follow.by contin.  TEICOWIN, Zentiva [P/S]   cocc.infects.in penicillin allergic pts./pts.fail.to respond to penicillin/
                                Teicoplanin.
   IV infus.dil.in 0,9% NaCl                                  cephalosporin, ser.sens.organ.infects/pts.fail.to respond to penicillin/
   For IV infus.dil.300 mg in 50 ml dil.(i.e 6 mg/ml) or more & infus.over   Indications: Potent.ser.G(+) infects.incl.those that cannot be treat.  cephalosporin., endocardit. in penicillin allergic pts.in combinat.with
                                with other antimicrob., endocardit., septicaem., osteomyelit., resp./
   10-45 mins. Admin.more than 1 200 mg in 1 hr infus.not recomm.  skin & soft tiss. infects., UTI, CAPD assoc.peritonit., prophylax.in   aminoglycosides, oral admin.in staphylococ. enterocolit. & antibiot.
   Contraindications: Lincomycin sens., GI dis. esp. colit.hist., safety   orthopaed./vasc.surg., orally for antibiot.assoc. diarrh. incl. pseu-  assoc.pseudomembr.colit.
   in pregn.& lactat.not est.   domembran.colit.              (S4) POWD.FOR INJ, [P/S] C/20.1.1/181, X/20.1.1/23.
   Side effects: GI disturbs.incl.sev./persist.diarrh. dur. or aft.  (S4) POWD.FOR SOL.FOR INJ. 41/20.1.1/0947, 0948  774731-028: 500 mg, 1x10 ml vials, R982,57
   treatm., pseudomembr.colit., hypersens. reacts., skin reacts.,   719385-001: 200 mg, 2 x 10 ml, R1 293,77  808431-021: 1 g, 1x20 ml, vials, R1 744,70
   bld.dyscras., abnorm.liv.funct. tests, jaund., anaphylact.reacts.,   Dosage: IV Admin.in dil.sol.at a rate of no more than 500 mg/½ hr.
   thrombophlebit.              719387-001: 400 mg, 1 x 20 ml, R1 274,62  Adults: 2 g IV dly.in div. dos. as 500 mg 6 hrly.or 1 g 12 hrly.
                                Dosage: Admin.as once daily dos.either IV or IM. IV inj.as either
   Special precautions: Other med.with neuromusc. block activ.,
   atop.pts., GI dis.hist., imp. liv./ ren.funct., discont.when signif.diarrh.  bolus or 30 min.infus.  Childr: 40 mg/kg bm/day IV in div.dos. Infts.& neonates: Init.tot.
                                                              dly. IV dos: 15 mg/ kg follow.by 10 mg/kg 12 hrly.in 1st wk.of life &
                                A 2  inj.should be admin.on first day in sev. infects. Respons.usual.
                                  nd
   occurs, admin. therapeut.dos.in treatm.of beta haemolyt. streptococ.
   infect.for at least 10 days.  within 48-72 hrs. Ther. durat. determ.by type & sev.of infect.& clinic.   8 hrly. thereaft. till 1 mnth of age.
                                respons. Contin.treatm.for at least 3 days aft.pt. afebrile & aft.clin.
                                                              Antibiot.assoc.pseudomembr.colit: Oral admin: Dil. in 30 ml
   SPEC TEICOPLANIN, (Specpharm & Pfizer) Specpharm [P/S]  sympts.disapp. Endocardit. & osteomyelit: 3 wks.or long.treatm.  water/flav. Adults: Tot.dly. dos.of 500 mg-2 g in 3-4 div.dos.x 7-10
   Teicoplanin.                 recomm. Do not admin.for long.than 4 mnths.  days. Childr: Tot.dly. dos. of 40 mg/kg bm in 3-4 div.dos.with max.
   Indications: Potent.ser.G(+) infects.incl.those that cannot be treat.  Adults & elderly pts.with norm.ren.funct:   tot. dly. dos.of 2 g
   with other antimicrob., endocardit., septicaem., osteomyelit., resp./  Mod.infects: Load.dos: 400 mg as sngl.IV inj.on 1st day. Maint:   Contraindications: Safety in pregn.& lactat.not est., not for IM use
   skin & soft tiss. infects., UTI, CAPD assoc.peritonit., prophylax. in   200 mg dly.IV/IM.  Side effects: Anaphylax., hypersens.reacts., pain/ musc.spasm chest
   orthopaed./vasc.surg.        Sev.infects: Load.dos: 400 mg IV 12 hrly.for first 3 dos. Maint:   & back, interstit.nephrit., nephro./ ototox., vertigo, dizzin., tinnit., bld.
   (S4) POWD.& SOLV.FOR SOL.FOR INJ. 42/20.1.1/0888, 0889,   400 mg dly.IV/IM. Dos.of up to 12 mg/ kg may be reqd. Adapt.in   dyscras., loc.reacts.at inj.site, flush.red neck syndr., Stev.-Johns.syndr.,
   42/34/1056                   overweight pts.               tox.epiderm.necrolys., vasculit., card.arrest, shock, pseudomembr.co-
   717364-001: 200 mg, 1 vial, R129,83  Prophylax.in orthopaed.& vasc.surg: 400 mg as sngl.IV inj.at   lit., fev., chills, naus., hypotens.
   717365-001: 400 mg, 1 vial, R290,91  induct.of anaesthes.  Special precautions: Superinfect., inflamm. intestin. mucosa dis-
   Dosage: Admin. IV or IM. IV inj.as either bolus or 30 min.infus. Dos.  Oral treatm.of antibiot.assoc.diarrh: Aft. reconstit. (see lit) admin   ords., pseudomembr.colit., underly. ren. dysfunct., concom.neuro-&
   usual. once dly. A 2  inj.should be admin.on first day in sev.infects.   200 mg orally 2xdly x10 days.  nephrotox. antibiot. & ototox.agents, underly.hear.loss & deafn. pe-
           nd
   Respons. usual. within 48-72 hrs. Ther.durat.determ.by type & sev.  Adults & elderly pts.with.ren.impairm:   riod., leucocyte count monitor., elderly.
   of infect.& clinic respons. Endocardit.& osteomyelit: 3 wks.or long.  CAPD: Sngl.IV load.dos.of 400 mg, then if pt. febrile  20 mg/L per   Drug interactions: Skin reacts., flush.in childr. with anaesth.agents
                                                nd
                                    st
   treatm.recomm. Do not admin.for long.than 4 mnths.  bag in 1  wk, 20 mg/L/alt. bags in 2  wk & 20 mg/L in overnight
                                        rd
   Adults & elderly pts.with norm.ren.funct:   dwell bag only in 3  wk.  LINEZOLID HETERO 600 MG, (Sanofi-Aventis) Hetero [P/S]
   Mod.infects: Load.dos: 400 mg as sngl.IV inj.on 1st day. Maint:   Childr.from 3 yrs:   Linezolid

   200 mg dly.IV/IM.            Sev.infects.& neutropen.pts: 10 mg/kg 12 hrly by IVI for first3 dos.  Indications: Vancomycin-resist.Enterococcus faecium infects.incl.
   Sev.infects: Load.dos: 400 mg IV 12 hrly.for first 3 dos. Maint:   then 10 mg/kg IV/IM as sngl. dly. dos.  concurr.bacteraem., nosocom. / commun.acquir. pneumon.caus.by
   400 mg dly.IV/IM. Dos.of up to 12 mg/kg may be reqd. Adapt.in   Mod.infects: 10 mg/kg 12 hrly by IVI for 1  3 dos. thereaft. 6 mg/  Staphylococc. aureus (methicilllin-suscept.& -resist.strains) or Strep-
                                                   st
   overweight pts.              kg IV/IM as sngl.dly.dos.     tococc.pneumoniae (incl.multi-med.resist.S pneumoniae strains), incl.
   Prophylax.in orthopaed.& vasc.surg: 400 mg as sngl.IV inj.at   Contraindications: Safety & effic.in childr.und. 3 yrs.not est., safety   cases with concurr. bacteraem, or Staphylococc. aureus.
   induct.of anaesthes.         in pregn.& lactat.not est., subarachnoid space inj, pts.with creatin.  (S4) TABS, 48/20.1.1/ 0081
   Childr.from 3 yrs:           clear ≤ 20 ml/min.            721171-001: 600 mg, 10, R5 688,73
   Sev.infects.& neutropen.pts: 10 mg/kg 12 hrly by IVI for first3 dos.  Side effects: Trombocytopen., eosinophil., leucopen., hypersens./  721141-002: 600 mg, 30, R17 066,27

   then 10 mg/kg IV/IM as sngl. dly. dos.  anaphylact.reacts, fev., bronchosp., skin/inj. site reacts., GI disturbs.,   Dosage: May be used as init.ther. Adults & adolesc.12 yrs & old:
                     st
   Mod.infects: 10 mg/kg 12 hrly by IVI for 1  3 dos. thereaft. 6 mg/  headache, dizzin., hear.loss/tinnit./vestibul. disturbs. in combinat.  Commun.acquir. & nosocom. pneum. incl. concurr.bacteraem:
   kg IV/IM as sngl.dly.dos.    with potent.ototox.meds.      600 mg 2xdly x 10-14 consec. days.
   CAPD: Sngl.IV load.dos.of 400 mg, then 20 mg/L bag in 1  wk, 20 mg/L/  Warnings and special precautions: Not known if pass.into breast   Enterococc.infects incl.vancomycin-resist. infects. & those
                         st
   alt.bags in 2  wk & 20 mg/L in overnight dwell bag only in 3  wk.  milk, vancomycin-cross-sens., monit.ther.in ren.insuffic., period.hae-  with concurr.bacteraem: 600 mg 2xdly.x14-28 consec. days. Com-
        nd
                           rd
   Contraindications: Safety & effic.in childr.und. 3 yrs.not est., safety   matolog./ liv.& ren.funct.tests advis.dur.prolong.treatm., reg. eval.of   bin. ther. may be clinic.indicat.if document./presumpt. pathogens incl.
   in pregn.& lactat.not est., subarachnoid space inj.  pt.condit.essent., superinfect., monit.ren.& audit.funct.in concurr./   Gram-neg.organisms.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page284.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page280.html">280</a>&nbsp;&nbsp;&nbsp;<a href="page281.html">281</a>&nbsp;&nbsp;&nbsp;<a href="page282.html">282</a>&nbsp;&nbsp;&nbsp;<a href="page283.html">283</a>&nbsp;&nbsp;&nbsp;<a href="page284.html">284</a>&nbsp;&nbsp;&nbsp;<a href="page285.html">285</a>&nbsp;&nbsp;&nbsp;<a href="page286.html">286</a>&nbsp;&nbsp;&nbsp;<a href="page287.html">287</a>&nbsp;&nbsp;&nbsp;<a href="page288.html">288</a>&nbsp;&nbsp;&nbsp;<a href="page289.html">289</a>&nbsp;&nbsp;&nbsp;<a href="page290.html">290</a>
             </td>
             <td width="35%"><a href="page286.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page286.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
